Cosmetic products application in patients with chronic dermatosis (atopic dermatitis, eczema)

Khardikova S.A.; Martynova V.G.; Semchenko E.A.

doi:https://doi.org/10.17116/klinderma202322051601

Khardikova S.A.

Siberian State Medical University of the Ministry of Health of Russia

ORCID: 0000-0001-9496-1221

Martynova V.G.

Siberian State Medical University of the Ministry of Health of Russia

ORCID: 0000-0003-0320-9830

Semchenko E.A.

Siberian State Medical University of the Ministry of Health of Russia

ORCID: 0009-0000-5398-4267

Cosmetic products application in patients with chronic dermatosis (atopic dermatitis, eczema)

Authors:

Khardikova S.A., Martynova V.G., Semchenko E.A.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2023;22(5): 601‑605

DOI: 10.17116/klinderma202322051601

Read: 2175 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Khardikova SA, Martynova VG, Semchenko EA. Cosmetic products application in patients with chronic dermatosis (atopic dermatitis, eczema). Russian Journal of Clinical Dermatology and Venereology. 2023;22(5):601‑605. (In Russ.)
https://doi.org/10.17116/klinderma202322051601

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To determine the efficacy and safety of cosmetics with pH 5.0 application in patients with chronic dermatosis (atopic dermatitis, eczema) using a moisturizing emulsion, cream and cleansing gel.

MATERIAL AND METHODS

There were 30 patients aged between 18 and 40 years (8 men and 22 women) under our supervision, 15 of them with atopic dermatitis and 15 with eczema. The diagnosis was made based on complaints, history and clinical picture of the disease. The efficacy of cosmetic products’ complex was evaluated by the dynamics of skin dryness and moisturizing. At the beginning of the treatment patients were given topical glucocorticosteroids 2 times a day for 14 days, then 2 times a week for 2 weeks and special skin care products on the other days for 4 weeks. For all patients with atopic dermatitis the SCORAD index was determined before and at the end of treatment, and for those with eczema — the EASI score and the index of itching by the VAS scale.

RESULTS

The positive results were received in all patients after treatment. The patients noted in dryness and moisturizing of skin. Side effects against the background of the conducted therapy were not registered. The use of special skin care products was positively evaluated.

CONCLUSION

The results of the study allow to recommend the inclusion in comprehensive therapy of patients with atopic dermatitis and eczema of special skin care products (moisturizing emulsion, restorative cream and cleansing gel), which help to restore skin barrier, that in turn leads to a significant reduction in skin dryness. These cosmetics can be characterized as effective, safe and recommended for clinical practice.

Keywords:

barrier function

xerosis

filaggrin

atopic dermatitis

eczema

skin pH

skin moisturizing

special cosmetic products

Authors:

Khardikova S.A.

Siberian State Medical University of the Ministry of Health of Russia

ORCID: 0000-0001-9496-1221

Martynova V.G.

Siberian State Medical University of the Ministry of Health of Russia

ORCID: 0000-0003-0320-9830

Semchenko E.A.

Siberian State Medical University of the Ministry of Health of Russia

ORCID: 0009-0000-5398-4267

Received:

10.08.2023

Accepted:

06.09.2023

Close metadata

References:

Murashkin NN, Materikin AI, Ambarchyan ET, Epishev RV, Fedorov DV. Innovations in the treatment of atopic dermatitis complicated by secondary infection. Pediatricheskaya farmakologiya. 2018;4. (In Russ.). Accessed July 30, 2023. https://cyberleninka.ru/article/n/innovatsii-v-terapii-atopicheskogodermatitaoslozhnennogo-vtorichnoy-infektsiey
Elias PM. Stratum Corneum Defensive Functions: An Integrated View. Journal of Investigative Dermatology. 2005;125(2):183-200. https://doi.org/10.1111/j.0022-202X.2005.23668.x
Chernova ID, Morozov AV, Voskanyan OS. Cosmetic skin care with acquired dryness syndrome. Trends in the Development of Science and Education. 2019;55(4):40-44. (In Russ.). https://doi.org/10.18411/lj-10-2019-64
Belousova TA, Goryachkina MV. Modern ideas about the structure and function of the skin barrier and therapeutic possibilities of correction of disorders. Russian Medical Journal. 2004;12:1082-1085. (In Russ.). https://doi.org/10.25208/vdv1063
Augustin M, Wilsmann-Theis D, Korber A, et al. Diagnosis and treatment of xerosis cutis. Journal of German Society of Dermatology. 2018;16(4):3-35. https://doi.org/10.1111/ddg.13906
Paul C, Maumus-Robert S, Mazereeuw-Hautier J, et al. Prevalence and risk factors for Xerosis in the elderly: A cross-sectional epidemiological study in primary care. Dermatology. 2011;223(3):260-265. https://doi.org/10.1159/000334631
Hahnel E, Blume-Peytavi U, Trojahn C, et al. Prevalence and associated factors of skin diseases in aged nursing home residents: A multicentre prevalence study. BMJ Open. 2017;7(9):1-9. https://doi.org/10.1136/bmjopen-2017-018283
Tamrazova OB, Molochkov AV. Skin xerosis is the main pathogenetic factor in the development of atopic dermatitis. Dermatology. Appendix to the Journal Consilium Medicum. 2014;4:48-54. (In Russ.).
Cookson W. The immunogenetics of astma andeczema: A new focus on the epithelium. Nat Rev Immunol. 2000;4:978-988. https://doi.org/10.1038/nri1500
Loden M, Maibach HI. Treatment of Dry Skin Syndrome. Springer-Verlag Berlin Heidelberg. Springer, Part of Springer Science + Business Media. 2012:3-73.
Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss of function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38:441-446. https://doi.org/10.1038/ng1767
O’Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. Journal of Allergy and Clinical Immunology. 2008;122:689-693. https://doi.org/10.1016/j.jaci.2008.08.002
Sandilands A, Smith FJ, Irvine AD, McLean WH. Filaggrin’s fuller figure: a glimpse into the genetic architecture of atopic dermatitis. Journal of Investigative Dermatology. 2007;127:1282-1284. https://doi.org/10.1038/sj.jid.5700876
Saba M Ali, Gil Yosipovitch. Skin pH: From Basic Science to Basic Skin Care. Acta Derm Venereol. 2013;93:261-267. https://doi.org/10.2340/00015555-1531
Coiffard L, Couteau C. Soap and syndets: differences and analogies, sources of great confusion. European Review for Medical and Pharmacological Sciences. 2020;24:11432-11439. https://doi.org/10.26355/eurrev_202011_23637
Panther DJ, Jacob SE. The Importance of Acidification in Atopic Eczema: An Undererexplored Avenue for Treatment. Journal of Clinical Medicine. 2015;5:970-978. https://doi.org/10.3390/jcm4050970
Lichterfeld-Kottner A, El Genedy, et al. Maintaining skin integrity in the aged: review. International Journal of Nursing Studies. 2020;103:103509. https://doi.org/10.1016/j.ijnurstu.2019.103509